Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3919582
Max Phase: Preclinical
Molecular Formula: C23H23FN4O3
Molecular Weight: 422.46
Molecule Type: Small molecule
Associated Items:
ID: ALA3919582
Max Phase: Preclinical
Molecular Formula: C23H23FN4O3
Molecular Weight: 422.46
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CCCc1nc2ccc(NC(=O)N3CCC(c4noc5ccc(F)cc45)CC3)cc2o1
Standard InChI: InChI=1S/C23H23FN4O3/c1-2-3-21-26-18-6-5-16(13-20(18)30-21)25-23(29)28-10-8-14(9-11-28)22-17-12-15(24)4-7-19(17)31-27-22/h4-7,12-14H,2-3,8-11H2,1H3,(H,25,29)
Standard InChI Key: ZVWKGLGQTXILAQ-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 422.46 | Molecular Weight (Monoisotopic): 422.1754 | AlogP: 5.47 | #Rotatable Bonds: 4 |
Polar Surface Area: 84.40 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 1 |
#RO5 Violations: 1 | HBA (Lipinski): 7 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 12.79 | CX Basic pKa: 0.86 | CX LogP: 3.87 | CX LogD: 3.87 |
Aromatic Rings: 4 | Heavy Atoms: 31 | QED Weighted: 0.47 | Np Likeness Score: -1.99 |
1. (2016) Substituted piperidinyl-carboxamide derivatives useful as SCD 1 inhibitors, |
Source(1):